Serum levels of IL-22 are increased in patients with anemia secondary to chronic kidney disease and myelodysplastic syndromes, and the IL-22 receptor, IL-22RA1, is present on erythroid precursors, with blockade of IL-22 signaling alleviating anemia in mice (192). Here, IL22 is linked to chronic kidney disease.